---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-107408"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2022-10-11T23:59:59+00:00"
generated_at: "2026-06-23T04:28:21.066901+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Passage Bio appoints William Chou as CEO, replacing interim CEO Chip Cale

## Summary
- William Chou appointed CEO and director effective October 10, 2022.
- Edgar B. Cale resigned as interim CEO; continues as General Counsel and Corporate Secretary.
- Dr. Chou receives $580k base salary, 55% target bonus, and $200k sign-on bonus with clawback.
- Granted option to purchase 885,000 shares vesting over 4 years.
- Severance includes 12 months base salary plus bonus on termination without cause.

## SEC filing metadata
- accession: 0001104659-22-107408
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2022-10-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/0001104659-22-107408-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/tm2227279d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-107408
- JSON: https://secwatch.observer/filing/0001104659-22-107408.json
- Plain text: https://secwatch.observer/filing/0001104659-22-107408.txt

## Key facts
- Executive change
  Edgar B. (Chip) Cale resigned as Interim Chief Executive Officer at Passage BIO, Inc..
  - Action: resigned
  - Role: Interim Chief Executive Officer
  source text: Edgar B. (Chip) Cale resigned from his position as the Company’s Interim Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/0001104659-22-107408-index.htm
- Executive change
  William Chou was appointed as Chief Executive Officer and Director at Passage BIO, Inc..
  - Action: appointed
  - Role: Chief Executive Officer and Director
  source text: the board of directors (the “Board”) of Passage Bio, Inc. (the “Company”) appointed William Chou, M.D., age 50, as (i) Chief Executive Officer and (ii) a member of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465922107408/0001104659-22-107408-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.